Sangeeta Lakhi 
Dealstreet

Rajani Associates advises Sudarshan Pharma on $20 Million FCCB issue

Sudarshan Pharma is engaged in the pharmaceutical business and is known for manufacturing and trading, inter alia, specialty chemicals, agro chemicals, and paints.

Bar & Bench

Sudarshan Pharma Industries Limited has raised $20 million by way of a Foreign Currency Convertible Bonds (FCCB) issue.

Rajani Associates advised Sudarshan Pharma on this FCCB issue.

The transaction was led by Sangeeta Lakhi (Senior Partner), with support from Associates Sommya Khandelwal, Dipendra Singh Tomar and Rishi Sharma.

Sudarshan Pharma

Sudarshan Pharma is engaged in the pharmaceutical business and is known for manufacturing and trading, inter alia, specialty chemicals, agro chemicals, and paints. The Company also provides customized specialty chemicals to customers in India and overseas.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Khaitan & Co advises HCL Group company on semiconductor JV with Foxconn

Cryptocurrency may be legal but no immunity for defrauding investors: Orissa High Court

Universal Legal advises Gorilla Technology on strategic investment in Astrikos.AI

LKS advises Indoco Remedies on ₹110 crore ophthalmic business transfer to Sunways

Supreme Court Gender Sensitisation panel gets new members; Justice BV Nagarathna continues as head

SCROLL FOR NEXT